Human CX3CL1/Fractalkine Chemokine Domain Antibody Summary
Gln25-Arg339 (Ser199Asn) (predicted)
Accession # P78423
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CX3CL1/Fractalkine
CX3CL1, also named neurotactin, is a novel chemokine identified through bioinformatics. CX3CL1 has a unique C-X3-C cysteine motif near the amino-terminus and is the first member of a fourth branch of the chemokine superfamily. Unlike other known chemokines, CX3CL1 is a type 1 membrane protein containing a chemokine domain tethered on a long mucin-like stalk. Human CX3CL1 cDNA encodes a 397 amino acid (aa) residue membrane protein with a 24 aa residue predicted signal peptide, a 76 aa residue chemokine domain, a 241 aa residue stalk region containing 17 degenerate mucin-like repeats, a 19 aa residue transmembrane segment and a 37 aa residue cytoplasmic domain. The extracellular domain of human CX3CL1 can be released, possibly by proteolysis at the dibasic cleavage site proximal to the membrane, to generate soluble CX3CL1. CX3CL1 mRNA has been detected in various tissues including the brain and heart. The expression of CX3CL1 was also reported to be up-regulated in endothelial cells and microglia by inflammatory signals. Membrane-bound CX3CL1 has been shown to promote adhesion of leukocytes. The soluble chemokine domain of human CX3CL1 was reported to be chemotactic for T cells and monocytes while the soluble chemokine domain of mouse CX3CL1 was reported to chemoattract neutrophils and T-lymphocytes but not monocytes.
- Pan, Y. et al. (1997) Nature 387:611.
- Bazan, J.F. et al. (1997) Nature 385:640.
- Mackay, C.R. (1997) Current Biology 7:R384.
Product Datasheets
Citations for Human CX3CL1/Fractalkine Chemokine Domain Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
9
Citations: Showing 1 - 9
Filter your results:
Filter by:
-
CX3CL1(+) Microparticles-Induced MFG-E8 Enhances Apoptotic Cell Clearance by Alveolar Macrophages
Authors: WH Tsai, SC Chang, YC Lin, HC Hsu
Cells, 2021-09-28;10(10):.
Species: Human
Sample Types: Microparticles
Applications: Flow Cytometry -
Shear Stress Counteracts Endothelial CX3CL1 Induction and Monocytic Cell Adhesion
Authors: A Babendreye, L Molls, D Dreymuelle, S Uhlig, A Ludwig
Mediators Inflamm., 2017-03-26;2017(0):1515389.
Species: Human
Sample Types: Whole Cells
Applications: Functional Assay -
Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity.
Authors: Suzuki F, Kubota T
Arthritis Res. Ther., 2012-03-06;14(2):R48.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-Fr -
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis.
Authors: Truman LA, Ford CA, Pasikowska M, Pound JD, Wilkinson SJ, Dumitriu IE, Melville L, Melrose LA, Ogden CA, Nibbs R, Graham G, Combadiere C, Gregory CD
Blood, 2008-09-17;112(13):5026-36.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
IFN-gamma alters the response of Borrelia burgdorferi-activated endothelium to favor chronic inflammation.
Authors: Dame TM, Orenzoff BL, Palmer LE, Furie MB
J. Immunol., 2007-01-15;178(2):1172-9.
Species: Human
Sample Types: Whole Cells
Applications: Cell-based ELISA -
The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro.
Authors: Faure V, Cerini C, Paul P, Berland Y, Dignat-George F, Brunet P
Int. Immunol., 2006-09-05;18(10):1453-9.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Fractalkine reduces N-methyl-d-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation.
Authors: Deiva K, Geeraerts T, Salim H, Leclerc P, Hery C, Hugel B, Freyssinet JM, Tardieu M
Eur. J. Neurosci., 2004-12-01;20(12):3222-32.
Species: Human
Sample Types: Whole Cells, Whole Tissue
Applications: ICC, IHC-Fr -
Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth.
Authors: Chazaud B, Sonnet C, Lafuste P, Bassez G, Rimaniol AC, Poron F, Authier FJ, Dreyfus PA, Gherardi RK
J. Cell Biol., 2003-12-08;163(5):1133-43.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo.
Authors: Lucas AD, Chadwick N, Warren BF, Jewell DP, Gordon S, Powrie F, Greaves DR
Am. J. Pathol., 2001-03-01;158(3):855-66.
Species: Human
Sample Types: Cell Lysates, Whole Cells, Whole Tissue
Applications: ICC, IHC, Western Blot
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human CX3CL1/Fractalkine Chemokine Domain Antibody
There are currently no reviews for this product. Be the first to review Human CX3CL1/Fractalkine Chemokine Domain Antibody and earn rewards!
Have you used Human CX3CL1/Fractalkine Chemokine Domain Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image